Targeting inflammation as cancer therapy

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Inflammation is a biological response to injury and infection.
• Decades of research highlight inflammation's complex role in cancer progression, including tumor development, invasion, metastasis, and treatment resistance.

Purpose of the Study:

• To review the dynamic inflammatory tumor microenvironment.
• To discuss key inflammation mediators in cancer.
• To highlight inflammation-targeted therapies for antitumor responses.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of inflammatory cells, cytokines, and intracellular pathways.
• Examination of inflammation-targeted agents' mechanisms.

Main Results:

• Inflammation is integral to the tumor microenvironment.
• Key mediators include inflammatory cells and cytokines.
• Inflammation-targeted agents can suppress cancer and improve treatment efficacy.

Conclusions:

• Targeting inflammation offers a promising strategy for cancer therapy.
• Understanding inflammation's role is crucial for developing novel antitumor treatments.
• Preclinical and clinical data support the translation potential of inflammation-targeted therapies.